The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications.
about
Counteracting Protein Kinase Activity in the Heart: The Multiple Roles of Protein PhosphatasesIon Channels in the HeartInflammation and C-reactive protein in atrial fibrillation: cause or effect?Calcium dysregulation in atrial fibrillation: the role of CaMKIIPitx2, an atrial fibrillation predisposition gene, directly regulates ion transport and intercalated disc genes.Disrupted calcium release as a mechanism for atrial alternans associated with human atrial fibrillationRecent advances in the molecular pathophysiology of atrial fibrillation.Human atrial action potential and Ca2+ model: sinus rhythm and chronic atrial fibrillation.Oxidized CaMKII causes cardiac sinus node dysfunction in mice.Inhibition of CaMKII phosphorylation of RyR2 prevents induction of atrial fibrillation in FKBP12.6 knockout mice.Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation.The Use of Gene Therapy for Ablation of Atrial Fibrillation.Mutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization.Altered Excitation-Contraction Coupling in Human Chronic Atrial Fibrillation.Atrial Fibrillation and Metabolic Syndrome: Understanding the Connection.Atrial fibrillation: mechanisms, therapeutics, and future directions.2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial designNovel molecular targets for atrial fibrillation therapy.Calcium handling and atrial fibrillation.New directions in antiarrhythmic drug therapy for atrial fibrillation.Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia.Emerging roles of junctophilin-2 in the heart and implications for cardiac diseases.Novel therapeutic targets in the management of atrial fibrillation.Role of tumor necrosis factor alpha in the pathogenesis of atrial fibrillation: A novel potential therapeutic target?New antiarrhythmic targets in atrial fibrillation.Prevention of Atrial Fibrillation by Using Sarcoplasmic Reticulum Calcium ATPase Pump Overexpression in a Rabbit Model of Rapid Atrial Pacing.A map of human circular RNAs in clinically relevant tissues.A low-dose β1-blocker effectively and safely slows the heart rate in patients with acute decompensated heart failure and rapid atrial fibrillation.Triggered activity in atrial myocytes is influenced by Na+/Ca2+ exchanger activity in genetically altered mice.Autonomic Tone Activity Before the Onset of Atrial Fibrillation.Cellular and molecular correlates of ectopic activity in patients with atrial fibrillation.Synaptic Plasticity in Cardiac Innervation and Its Potential Role in Atrial Fibrillation.Cavβ2 transcription start site variants modulate calcium handling in newborn rat cardiomyocytes.Anticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms
P2860
Q26776182-4C486778-9542-4F19-843B-9618B34EF111Q26829681-68369429-61FD-4F5C-989D-760C9867A481Q26865381-1DBAB776-12EE-419D-8B36-7C58444B869FQ27027326-F806D3FD-90D6-4958-9D19-0E8492E8A283Q33580059-CFCA3AFF-6B4D-4949-9FD0-ECE2696326D6Q34679604-3479A2AC-3D3B-418B-BA74-FD93E1D18988Q35142870-0421A6E0-B890-4AA1-AFAF-72133496F0F3Q35528532-631DF5AC-0723-4549-A120-C43E3592DF58Q35572691-974D5C37-23FA-4568-9996-81DBF41A4D18Q35737061-5870AC01-A872-4A2F-9C81-5E6472C4E76CQ36331025-85997E89-2C46-48B3-B638-8D3ED60DAA9EQ36458906-BBEC1E2F-88B5-4B24-A2AD-AA8EB9D9DBA5Q37315854-F77DDBA3-52B8-4E71-869C-0781A41046A4Q37496226-411688B7-20B4-4A66-9B16-04D5A8486470Q37496267-D0DC919A-218C-41E3-8678-462262A80FA2Q37590158-8ED3005D-7E18-4394-B8D2-DBB262F0B4C3Q37989837-A8DB1A71-B459-45BF-9BED-D906F98F51C6Q37998312-4D296113-86FE-49DC-BCE1-468004761B89Q38018509-C44516DE-FBD1-4398-9A15-82398D5205A3Q38069201-57DD5D17-FF14-4E30-A19C-9B4C08FB4D3CQ38201409-407394CD-7E26-469B-8AF6-903AE7022409Q38220760-31F8E4C8-3B41-468A-B979-9DBAFA43F936Q38236746-ABA396FC-E29D-411C-A178-F22AF8B3227CQ38486305-16B577B5-C3C3-4366-A520-B146AB8BDDDAQ38648539-5E978717-65B6-4BF9-B77A-21F7585F1909Q40082023-14DB3938-4565-4AE4-A5A6-EDEF0669CEB1Q43061380-A25C4BC3-B7EC-40FF-9D73-079661433AB0Q44398989-510AF5B6-D5FE-4C49-A716-125B90C94DF9Q49172061-42D442BA-7243-49EC-A0D8-1AF2166A72F5Q51012992-0E19FC31-1BA5-40B8-BCF6-2308EF13D16EQ51305092-980C8C03-8DC1-4D46-806E-2AAF94279450Q52608731-DC540B83-F5A9-4D48-AD2A-9FBD0818F004Q53382482-FF4CB5D1-BDB6-4573-858B-DB906EBC58A3Q58554222-C2098ECE-C4BF-4E3E-8790-8A2EF75D9485
P2860
The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The ryanodine receptor channel ...... and therapeutic implications.
@en
The ryanodine receptor channel ...... and therapeutic implications.
@nl
type
label
The ryanodine receptor channel ...... and therapeutic implications.
@en
The ryanodine receptor channel ...... and therapeutic implications.
@nl
prefLabel
The ryanodine receptor channel ...... and therapeutic implications.
@en
The ryanodine receptor channel ...... and therapeutic implications.
@nl
P2860
P356
P1476
The ryanodine receptor channel ...... and therapeutic implications.
@en
P2093
Dobromir Dobrev
Niels Voigt
P2860
P304
P356
10.1093/CVR/CVQ324
P577
2010-10-12T00:00:00Z